Literature DB >> 11504740

Thalidomide in the treatment of plasma cell malignancies.

S V Rajkumar, R A Kyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11504740     DOI： 10.1200/JCO.2001.19.16.3593

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  New drugs for the anorexia-cachexia syndrome.

Authors:  Mellar P Davis
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

2.  Continuous low dose of melphalan and prednisone in patients with multiple myeloma of very old age or severe associated disease.

Authors:  Alessandro Pulsoni; Nicoletta Villivà; Elena Cavalieri; Paolo Falcucci; Giacinto La Verde; Roberta Matera; Maria Teresa Petrucci; Maria Elena Tosti; Franco Mandelli
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.

Authors:  Waqas Rehman; Lisa M Arfons; Hillard M Lazarus
Journal:  Ther Adv Hematol       Date:  2011-10

4.  A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response.

Authors:  L W Vestermark; E Holtved; R Dahlrot; M K Brimnes; I M Svane; L Bastholt
Journal:  Ecancermedicalscience       Date:  2008-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.